Medical News

RSS

New guidelines urge opt-out tobacco treatment during hospital stays

For people who smoke cigarettes, a hospital stay may be an opportunity to quit. New clinical guidelines developed with experts from MUSC Hollings Cancer Center call on hospitals to make tobacco treatment a routine part of care.

5 Nov 2026

AI-designed vaccine provides complete protection against diverse bird flu variants

A University of Cambridge team has had a third success with their AI-guided technique for designing vaccines against highly infectious viruses that threaten animal and human health.

5 Nov 2026

ASH establishes new blood reference ranges for Duffy-null individuals

ASH has developed new reference ranges for children and adults with Duffy-null status, a common genetic trait associated with naturally lower circulating white blood cell counts that affects more than 66% of people with African or Mediterranean ancestry in the US.

5 Nov 2026

New AI framework improves early screening for Parkinson's disease

Scientists at Rensselaer Polytechnic Institute (RPI) have developed an artificial intelligence model to streamline and improve screening for Parkinson's disease (PD) so doctors can refer patients for early-stage testing.

5 Nov 2026

Vulnerable DNA sites make cancer cells sensitive to PARP inhibitors

A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows.

5 Nov 2026

Automated text messages improve bowel cancer screening in London

As low-cost and straightforward an intervention as automated text messaging could make a significant contribution to tackling London's below-average bowel cancer screening rates, according to a major study led by the University of Surrey.

5 Nov 2026

Compound YZG-331 leverages gut microbiota to improve sleep in mouse models of insomnia

This new article publication from Acta Pharmaceutica Sinica B discusses how interactions between the investigational compound YZG-331 and the gut microbiota contribute to its sleep-promoting effects in mouse models of insomnia.

5 Nov 2026

Anti-PEG antibodies drive contrasting liposome skin toxicity across species

This new article publication from Acta Pharmaceutica Sinica B discusses how anti-polyethylene glycol antibodies affect the movement of stealth liposomes from blood into skin, revealing contrasting distribution and toxicity patterns in mice and rats.

5 Nov 2026

Pattern-based patient selection associated with positive clinical trial results

This new article publication from Acta Pharmaceutica Sinica B discusses the association between using traditional Chinese medicine patterns to select participants and statistically significant primary outcomes in randomized placebo-controlled trials of Chinese herbal formulas.

5 Nov 2026

Review explores intrinsic mechanisms driving right ventricular remodeling in pulmonary arterial hypertension

Announcing a new article publication for Cardiovascular Innovations and Applications. Pulmonary arterial hypertension (PAH) comprises a group of progressive pulmonary circulatory diseases characterized by a persistent increase in pulmonary vascular resistance.

5 Nov 2026

New covalent inhibitor targets DNAJC9 to reduce sepsis inflammation

This new article publication from Acta Pharmaceutica Sinica B discusses the discovery of the covalent inhibitor A12 and the identification of DNAJC9 as a potential drug target for sepsis-associated inflammation.

5 Nov 2026

Innovative framework advances EEG-based emotion recognition

Emotion recognition plays an important role in understanding human cognition and behavior, and has potential applications in brain-computer interfaces and mental health monitoring.

5 Nov 2026

Delivering integrated HIV and substance use services through mobile units could save lives

Results from a clinical trial funded by the National Institutes of Health (NIH) in five major United States cities show that delivering integrated HIV and substance use disorder (SUD) services using peer navigation in mobile medical units reduced all-cause deaths by 71% compared to participants who received peer navigation to community-based services alone.

5 Nov 2026

Topadur’s Phase 2a trial of TOP-N53 for systemic sclerosis-associated digital ulcers advances to next dose levels

Topadur Pharma AG, a Swiss clinical-stage biopharmaceutical company, today announced that the Safety Review Committee of its Phase 2a trial has recommended progression to the next planned dose levels.

5 Nov 2026

Elusive HIV strains cause breakthrough infections after antibody treatment ends

The broadly neutralizing antibody VRC01 has been thoroughly vetted as a potential prophylactic that could prevent people from becoming infected with HIV.

5 Nov 2026

Rising colorectal cancer rates prompt earlier routine screening recommendations

Forty-five is the new 60 – at least when it comes to colonoscopies. That may not be the party you look forward to, but it could save your life. According to the Cancer Research Institute, 1 in 5 colorectal cancers are diagnosed in patients under age 55, making what was once thought of as an older person's disease one of the fastest-growing cancers in young people.

5 Nov 2026